These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25756634)

  • 21. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
    Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
    Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans.
    Lu K; Gray MA; Oliver C; Liley DT; Harrison BJ; Bartholomeusz CF; Phan KL; Nathan PJ
    Hum Psychopharmacol; 2004 Oct; 19(7):457-65. PubMed ID: 15378679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virtual Reality Exposure Therapy for Armed Forces Veterans with Post-Traumatic Stress Disorder: A Systematic Review and Focus Group.
    Vianez A; Marques A; Simões de Almeida R
    Int J Environ Res Public Health; 2022 Jan; 19(1):. PubMed ID: 35010723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
    Moylan S; Staples J; Ward SA; Rogerson J; Stein DJ; Berk M
    J Clin Psychopharmacol; 2011 Oct; 31(5):647-52. PubMed ID: 21869686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin Conductance Reactivity to Standardized Virtual Reality Combat Scenes in Veterans with PTSD.
    van 't Wout M; Spofford CM; Unger WS; Sevin EB; Shea MT
    Appl Psychophysiol Biofeedback; 2017 Sep; 42(3):209-221. PubMed ID: 28646388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virtual reality exposure therapy for the treatment of posttraumatic stress disorder: a methodological review using CONSORT guidelines.
    Motraghi TE; Seim RW; Meyer EC; Morissette SB
    J Clin Psychol; 2014 Mar; 70(3):197-208. PubMed ID: 24108479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alprazolam compared to clobazam and placebo in anxious outpatients.
    Castillo A; Sotillo C; Mariategui J
    Neuropsychobiology; 1987; 18(4):189-94. PubMed ID: 2900483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy and tolerance of alprazolam and bromazepam in flexible doses. Double-blind study in 119 ambulatory anxious patients].
    Ropert R; Bernes J; Dachary JM
    Encephale; 1987; 13(2):89-95. PubMed ID: 2885173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early onset anxiolytic efficacy after a single dose of pregabalin: double-blind, placebo- and active-comparator controlled evaluation using a dental anxiety model.
    Nutt D; Mandel F; Baldinetti F
    J Psychopharmacol; 2009 Nov; 23(8):867-73. PubMed ID: 18635690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancing prolonged exposure therapy for posttraumatic stress disorder with D-cycloserine: further support for treatments that promote experience-dependent neuroplasticity.
    Krystal JH
    Biol Psychiatry; 2012 Jun; 71(11):932-4. PubMed ID: 22579302
    [No Abstract]   [Full Text] [Related]  

  • 31. Virtually revolutionary.
    Iozzio C
    Sci Am; 2014 Oct; 311(4):26. PubMed ID: 25314861
    [No Abstract]   [Full Text] [Related]  

  • 32. Memory modification as an outcome variable in anxiety disorder treatment.
    Tryon WW; McKay D
    J Anxiety Disord; 2009 May; 23(4):546-56. PubMed ID: 19117720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal profile of brain response to alprazolam in patients with generalized anxiety disorder.
    Brown GG; Ostrowitzki S; Stein MB; von Kienlin M; Liu TT; Simmons A; Wierenga C; Stein OY; Bruns A; Bischoff-Grethe A; Paulus M
    Psychiatry Res; 2015 Sep; 233(3):394-401. PubMed ID: 26211623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An 87-year-old woman taking a benzodiazepine.
    Salzman C
    JAMA; 1999 Mar 24-31; 281(12):1121-5. PubMed ID: 10188664
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.
    Bailey JE; Papadopoulos A; Seddon K; Nutt DJ
    J Psychopharmacol; 2009 Mar; 23(2):117-22. PubMed ID: 18562427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The efficacy of alprazolam in the therapy of panic disorders].
    Diukova GM; Vorob'eva OV; Petrova EP; Smirnov SV; Tumalaeva ZN
    Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(4):9-13. PubMed ID: 8533521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An 87-year-old woman taking a benzodiazepine, 1 year later.
    Parker RA; Hartman EE
    JAMA; 1999 Nov; 282(20):1960. PubMed ID: 10580463
    [No Abstract]   [Full Text] [Related]  

  • 39. Treating anxiety disorders with virtual reality exposure therapy.
    Rothbaum BO; Garcia-Palacios A; Rothbaum AO
    Rev Psiquiatr Salud Ment; 2012; 5(2):67-70. PubMed ID: 22854576
    [No Abstract]   [Full Text] [Related]  

  • 40. A controlled clinical trial of alprazolam for the treatment of anxiety.
    Rickels K; Csanalosi I; Greisman P; Cohen D; Werblowsky J; Ross HA; Harris H
    Am J Psychiatry; 1983 Jan; 140(1):82-5. PubMed ID: 6128927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.